My Trading Account →
▾
Trading Profile Active
Active Trader
Verified Trader
⚡ My $100K Trading Account → ★ My Saved Watchlist →
🟢 My $100K Account → Today Screener 🏛️ Insiders
✓ Last Updated: Nov 16, 2026 • Verified SEC EDGAR, 13F & Cboe Data for 2027 RQD Quant Engine v6.2 Live

CME Group Inc. (CME) — RQD Stock Rating Cockpit

$306.31 -1.27% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $306.34

CME Group Inc. (CME) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (steady margins, 4% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- • BUY Cap $109.64B
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CME Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CME stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-22, CME Group Inc. (NASDAQ: CME) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $306.31 (-1.27% 1D, market cap $109.64B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 17/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CME ranks #41 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CME compare to ICE and SCHW in the Financials sector?
▼

Within the Financials sector (Investment Bankers/Brokers/Service), CME carries a Roarable B- (71/100 RQD), trailing P/E of 26.1x, gross margin of —, and ROIC of 3.5%. By comparison, ICE (Intercontinental Exchange Inc.) holds a B- grade (70/100 RQD, P/E 27.6x, ROIC 8.3%, cap $95.51B) and SCHW (Charles Schwab Corporation) posts a D+ grade (57/100 RQD, P/E N/A, ROIC 0.0%, cap $159.03B). Among the 5-stock peer group, CME leads on earnings multiple (26.1x) while HOOD leads on capital efficiency (27.5% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CME?
▼

Per CME's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001156375), CME Group Inc. generated $6.52B in revenue (+6.4% YoY), $4.07B in net income, and $4.19B in free cash flow against $198.42B in total assets and $76.36B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
🎯 CME TRADE EXECUTION LEVELS + TODAY'S TOP 3 TRADES EXACT ENTRY • HARD STOP-LOSS (SUP) • TARGET (RES) • WHY

Where to Enter $CME, Where to Set Your Hard Stop-Loss & Today's Top 3 High-Conviction Trades

🏆 RECENT ALERT WINNERS: $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
CURRENT TICKER SETUP • $CME R/R 2.9 : 1 • RQD 71/100 (B-)
$CME
Spot $306.31
1. GET IN (ENTRY)
$304.47–$307.84
2. HARD STOP (SUP)
$292.53 (-4.5%)
3. GET OUT (T1/T2)
$330.20 / $346.74
STOP-LOSS FLOOR (SUP $292.53): Hard stop sits 4.5% below spot to cap downside below key institutional support. If $CME closes a daily candle below $292.53, step aside.
PROFIT TARGETS (RES $330.20 / $346.74): Scale out 50% at T1 (+7.8%) and trail stop to breakeven for T2 (+13.2%).
Want this $CME sheet + Today's Top 3 Trades emailed free? Paper Trade $CME →
⚡ TODAY'S TOP 3 SUGGESTED TRADES OF THE DAY (100% FREE CHEAT SHEET) Trade #1 Unlocked • Enter Email Below to Unblur #2 & #3 + Get $CME Sheet
#1 • $ANET R/R 2.6 : 1
Arista Networks Inc.
IN
$164.14
STOP
$154.80
OUT
$178.00
#2 • 🔒 LOCKED R/R 2.6 : 1
AI Liquid-Cooling Leader
Target: +8.81% to +15.06% | Stop: -5.73%
#3 • 🔒 LOCKED R/R 2.3 : 1
Cash-Flow Buyback Machine
Target: +6.22% to +10.48% | Stop: -4.52%
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $306.34 (+0.01%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 13/20 (C) • 64.3% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record: Scores of 71/100 (B-) historically ranked in the Top 14% of excess returns over the next 90 days (+6.8% avg 90D alpha vs SPY • 68.4% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERBUY • B-
025507510071
Quant Analyst Panel Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw B- · Rk B
Cash (13)Whales (15)SEC (12)Macro (17)CEO (14)
Each axis scored 0–20
12M PRICE TARGET CONE+5.9% Base Target
$383 Bull$324 Base$251 Bear
📬 FREE CME RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CME)Realized 20D OHLCV Swing Band: ±1.9%
Deterministic 5-Pillar Attribution (71/100 Composite)
🔍 WHY CME SCORES 71/100 (B-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Macro Regime Fit+17/20 pts (24% of score)

FRED Regime × Technicals: 79% of 52W Range • RSI-14 at 51.6 (NEUTRAL RANGE)

▲ #2 Bullish Driver: Whale & Options Positioning+15/20 pts (21% of score)

20D Institutional Volume Accumulation (±1.9% realized swing band)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk12/20 pts (-8 pt drag)

Balance-sheet & 10-K footnote risk deducts 8 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
79
Grade A-$307.59+0.5% Next Q
Q2 (-2Q)
76
Grade B+$309.09+2.9% Next Q
Q3 (-1Q)
74
Grade B+$317.97-3.7% Next Q
Current
71
Grade B-$306.31+6.8% Hist 90D α
Trajectory: A- (79) → B- (71)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the CME Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 71/100 (B-) score, CME faces multiple-compression risk if 26.1x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($292.51) or 200D SMA ($282.06) invalidates the momentum regime and cuts Target Base ($324.23) toward Bear Floor ($251.17).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CME• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “CME Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
RSI-14 MOMENTUMNEUTRAL RANGE
51.630 Oversold · 70 Hot
ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)
3.80>3.0 Fortress Safe
PIOTROSKI F-SCOREHIGH QUALITY (7–9)
8 / 99-Pt Accounting
52-WEEK LASER RANGE79% OF RANGE
L: $218$306.31H: $329
1. Money & Cash Health● MIXED
Are profits real cash in the bank?

Decent core business (steady margins), though cash flow growth is moderate rather than explosive right now.

Factor Grade: CRQD 13 / 20
2. Big Money & Insiders● BUYING
Are whales & executives buying or selling?

Hedge funds and options traders are leaning bullish, showing strong institutional appetite.

Factor Grade: BRQD 29 / 40
3. Hidden Risks & Market Weather● ALL CLEAR
SEC fine-print scan & interest-rate fit

Clean SEC fine-print check with low hidden accounting risk and favorable interest-rate weather.

Factor Grade: BRQD 29 / 40
MULTI-MODEL QUANT PANEL DELIBERATION

Quant Analyst Panel Split (Battleground) on CME

Cash & Moat Bull AI
ROIC & Free Cash Flow Model
NEUTRAL (65)

3.5% ROIC with 42.0% gross margin and 3.95% FCF yield.

SEC Forensic Auditor AI
10-K Accruals & Altman-Z Guard
NEUTRAL (60)

Altman-Z 4.20 and Piotroski 8/9 pass balance-sheet audit.

Whale & Macro Hawk AI
Options Skew, 13F & Fed NetLiq
BULLISH (77)

29/40 institutional & smart-money positioning score with 17/20 macro alignment.

Bull Case: Why Buyers Like CME
  • ✓Big institutional funds and options desks are actively positioning on the bullish side.
  • ✓Company leadership has skin in the game with net positive insider conviction.
Bear Case: What Could Go Wrong
  • !Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (CME Tape Review)

  • ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
  • ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CME // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.41%📐 HORIZONTAL RANGE
2026-11-22O $310.3H $310.3L $306.3C $306.3VOL 2.45M
$326.4$297.1$267.8$238.5$209.2RES $320.9SUP $261.8$306.32026-05-262026-07-132026-08-272026-10-132026-11-22
🏛️ GURU-GRADE VALUATION & FORENSIC ACCOUNTING ENGINE NO MOAT (COST > RETURN) (ROIC 3.5% vs WACC 8.8%)

CME Intrinsic Fair Value Line, Peter Lynch Corridor, Forensic Trio & Warning Signs

1-SECOND VISUAL VALUATION ANCHOR (COMPOSITE DCF + PETER LYNCH + GRAHAM)
Fair Value: $222.57 vs Spot $306.31
MODESTLY OVERVALUED (-37.6%)
Undervalued Zone (< $189) Fair Value Corridor ($189–$256) Overvalued (> $256)
$306
⚡ INTERACTIVE 10-YEAR DCF SANDBOX

Test Your Own CME Growth & WACC Assumptions

YOUR DCF TARGET
$301.90
5-Yr Annual FCF Growth Rate: 8.8%
Discount Rate (WACC Hurdle): 8.8%
Year-10 Terminal FCF Multiple: 16.0x
Margin of Safety: -37.6% vs $306.31 Full DCF Table →
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CME Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
19.7%/yr Implied 5Y Growth

vs. +6.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CME today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →
CME → IBIT Confirmed Filing
Hedge funds executing delta-neutral cash-and-carry basis trades purchase spot IBIT shares while shorting regulated CME Bitcoin and Micro Bitcoin futures contracts, driving record CME crypto clearing volumes.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CME today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CME)

Financials Rank #41 of 1097 ⚔️ ICE vs CME Full Matrix →

1. Head-to-Head Financials Peer Comparison (CME vs. ICE, SCHW, BLK, HOOD)

Industry: Investment Bankers/Brokers/Service (64 Tracked Issuers)

Across 1097 tracked Financials securities in the Roarable RQD universe, CME Group Inc. (CME) ranks #41 by composite RQD confidence (71/100, grade B-) and #30 by equity capitalization ($109.64B). Within this direct 5-issuer industry benchmark cohort, CME leads on earnings valuation at 26.1x trailing P/E, while HOOD leads on capital efficiency and profitability with 27.5% ROIC and — gross margin. CME currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CME ACTIVE
CME Group Inc.
B- 71/100 26.1x — 3.5% -1.27% $109.64B Benchmark Subject
ICE
Intercontinental Exchange Inc.
B- 70/100 27.6x — 8.3% -0.52% $95.51B /ice-vs-cme →
SCHW
Charles Schwab Corporation
D+ 57/100 — — 0.0% -0.45% $159.03B /schw-vs-cme →
BLK
BlackRock Inc.
C- 59/100 32.8x — 6.2% -2.78% $175.53B /blk-vs-cme →
HOOD
Robinhood Markets Inc.
C- 59/100 43.8x — 27.5% -0.75% $61.82B /hood-vs-cme →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001156375 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), CME Group Inc. (CME) reported GAAP revenue of $6.52B (+6.4% vs. FY2024 revenue of $6.13B , and +16.9% cumulative change since FY2023) , GAAP net income of $4.07B, operating cash flow of $4.28B, and free cash flow of $4.19B (+16.6% YoY). On the balance sheet, CME closed FY2025 with $198.42B in total assets against $76.36B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 8/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $6.52B $4.07B $4.28B $4.19B $198.42B $76.36B
FY2024 (FY) 2024-12-31 $6.13B $3.53B $3.69B $3.60B $137.45B $49.93B
FY2023 (FY) 2023-12-31 $5.58B $3.23B $3.45B $3.20B $58.35B $13.65B

3. CME Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CME stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-22, CME Group Inc. (NASDAQ: CME) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $306.31 (-1.27% 1D, market cap $109.64B). Pillar breakdown: Fundamental Cash Engine 13/20, Institutional 13F & Options Flow 15/20, SEC Balance-Sheet Forensics 12/20, FRED Macro Regime Fit 17/20, and Executive Insider Alignment 14/20. Across 1097 tracked Financials issuers, CME ranks #41 in composite RQD confidence.

How does CME compare to ICE and SCHW in the Financials sector?

Within the Financials sector (Investment Bankers/Brokers/Service), CME carries a Roarable B- (71/100 RQD), trailing P/E of 26.1x, gross margin of —, and ROIC of 3.5%. By comparison, ICE (Intercontinental Exchange Inc.) holds a B- grade (70/100 RQD, P/E 27.6x, ROIC 8.3%, cap $95.51B) and SCHW (Charles Schwab Corporation) posts a D+ grade (57/100 RQD, P/E N/A, ROIC 0.0%, cap $159.03B). Among the 5-stock peer group, CME leads on earnings multiple (26.1x) while HOOD leads on capital efficiency (27.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CME?

Per CME's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001156375), CME Group Inc. generated $6.52B in revenue (+6.4% YoY), $4.07B in net income, and $4.19B in free cash flow against $198.42B in total assets and $76.36B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CME trading relative to its 50-day, 200-day, and 52-week technical levels?

CME last traded at $306.31 (-1.27% on volume of 2,452,180 shares), positioning the stock +4.72% above its 50-day simple moving average ($292.51) and +8.60% above its 200-day simple moving average ($282.06). Across its 52-week range of $218.31 to $329.16, CME sits at the 79.4% percentile with a 14-day RSI of 51.6 (NEUTRAL RANGE) and an implied next-earnings move of ±1.9% ($300.49 to $312.13).

ROARABLE RATING BRIEF • RQD 71/100 (B-) ✓ SEC XBRL & RQD VERIFIED

CME — CME Group Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

CME Group Inc. (CME) earns a live Roarable RQD composite score of 71/100, corresponding to a B- letter grade (Roarable Buy) at a spot price of $306.31 (-1.27% 1D, market capitalization $109.64B).

  • Fundamental Cash Engine (13/20): Anchored by return on invested capital (ROIC) of 3.5%, gross margin of —, operating margin of 64.9%, and free cash flow yield of 3.95%.
  • Whale 13F & Options Flow (15/20) + Insider Conviction (14/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (17/20) + Forensic Balance Sheet (12/20): Incorporates a 1.01x equity beta, Altman Z-Score of N/A, Piotroski F-Score of 8/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

CME Group Inc. Is a NASDAQ-listed issuer in the Financials sector, operating in the Investment Bankers/Brokers/Service industry. The profile identifies the company by sector, industry, and exchange, with a market capitalization of $106.1B. CME's regulated crypto futures clearing is referenced as a key activity, with record regulated crypto futures open interest cited from its Form 10-K.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), CME Group Inc. (CME) reported $6.52B in annual revenue (up from $6.13B in FY2024, +6.4% YoY) and $4.07B in GAAP net income. Over the multi-year SEC filing window from FY2023 ($5.58B revenue, $3.23B net income) through FY2025, CME scaled operating cash flow to $4.28B and free cash flow to $4.19B, backed by $198.42B in total assets against $76.36B in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (B- • RQD 71/100): Big institutional funds and options desks are actively positioning on the bullish side. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 13/20 and Institutional Whale Flow at 15/20, sustained execution supports upside toward the upper end of the $218.31 – $329.16 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins. Investors must weigh 26.1x trailing P/E and 40.2x EV/EBITDA against 64.9% operating margins and a 1.01x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The one documented ripple runs from CME's crypto futures clearing to IBIT, through basis arbitrage flows. A prospective investor should watch the monthly Cryptocurrency ADV and the CFTC Commitment of Traders Basis Report, which the graph names as the next catalysts. Basis compression toward short-term rate yields is the stated unwind trigger, meaning the tailwind is sensitive to rate and contango conditions. The competing-venue risk is the second-order threat to the clearing franchise.

  • Key Question #1: Can CME sustain or expand its 64.9% operating margin and 3.5% ROIC against Investment Bankers/Brokers/Service peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $6.52B and free cash flow of $4.19B, how will capital allocation balance growth reinvestment against $76.36B in total debt?
  • Key Question #3: How sensitive is CME's 24.3x forward P/E multiple to Financials capital spending cycles and macro interest-rate shifts (Beta 1.01x)?

CME Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for CME Group Inc. (CME) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CME Debate Forum (3) ↓
🟡 MARKET WIRE CME Group • 20d ago
Nikkei (JPY) Overview

CME Group report covering CME Group Inc. (CME) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CME Bull vs. Bear Conversation Board — What's Your Call at $306.31?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CME 🐻 33% BEARISH CONVICTION
1. Pick Your Side on CME:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $381.96 (+26.0%)
📌 Pinned Debate

Strong cash engine and macro-fit scores (17/20 macro regime fit with beta of 1.01) support a Roarable Buy rating of 72 out of 100.

Long CME at $303.14 targeting $381.96. Strong cash engine and macro-fit scores (17/20 macro regime fit with beta of 1.01) support a Roarable Buy rating of 72 out of 100.. Institutional whale score is 17/20 and the risk/reward vs. the $218.31 52-week low is skewed heavily in favor of bulls.

EarningsSniper 🐂 BULL

Both sides have a point here — CME's 12/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

RI RiskArb_Desk RQD DEBATE OPENER • Hedged Event Driven 🐻 BEARISH 🎯 Target: $236.45 (-22.0%)
Spot @ $303.14

Reported debt climbed from $13.65B to $76.36B over FY 2023–FY 2025 while ROIC sits at only 3.5% and EV/EBITDA is 40.2.

Sitting on the sidelines or leaning short CME above $303.14. Reported debt climbed from $13.65B to $76.36B over FY 2023–FY 2025 while ROIC sits at only 3.5% and EV/EBITDA is 40.2.. Until Fundamental Cash Engine (13/20) and FCF yield (3.95%) inflect higher, upside is capped near $329.16.

🎯 DAILY PRE-BELL WATCHLIST • ENTRY, HARD STOP & TARGET EDUCATIONAL LEVELS ONLY • EVERY TRADE CARRIES RISK

3 Stocks on Our Radar Today — Entry, Hard Stop & Why

📊 Recent Paper Examples (Not Typical Real-Money Results): $XYZ +15.6% (2d) $PLTR +13.7% (4d) $VRT +8.4% (2d)
TRADE #1 OF THE DAY R/R 2.6 : 1 • RQD 88 (A+)
$ANET Arista Networks Inc.
LONG (BUY SETUP)
1. Get In (Entry)
$164.14
2. Hard Stop
$154.80 (-5.7%)
3. Get Out (T1/T2)
$178.00 / $188.50
Entry Rule: Buy between $162.50 – $165.00 (or on 15-min candle reclaim above $165.40)
Stop Logic: Hard stop at $154.80 sits beneath the 50-day institutional demand shelf and October accumulation base—capping downside at -5.69% while targeting $178.00 to $188.50 (+14.84%).
4. Why Now: Microsoft (+6.68%) and Amazon (+6.12%) just surged while confirming $320B+ in data-center CapEx, yet passive ETF rebalancing pushed ANET down -2.79% to $164.14. Arista owns the 64.1% gross-margin 800G/1.6T back-end AI Ethernet switching monopoly that cashes those exact hyperscaler checks.
Horizon: 4–10 Trading Days (Supply-Chain Contagion Mean-Reversion Swing) Trade $ANET in $100K Arena →
TRADE #2 OF THE DAY R/R 2.6 : 1 • RQD 86 (A)
🔒 Setup #2: 130kW Direct-to-Chip Liquid Cooling & CDU Thermal Monopoly Pullback
LONG (BUY SETUP)
• Target Upside: +8.8% (T1) to +15.1% (T2)
• Max Downside Stop: -5.7% Hard Floor (2.6 : 1 R/R)
Order book sold out through 2027 on key VWAP support. Enter your email below for the ticker, buy trigger, and stop.
TRADE #3 OF THE DAY R/R 2.3 : 1 • RQD 85 (A)
🔒 Setup #3: 13.27x Forward P/E Money-Center Infrastructure Debt Underwriting Breakout
LONG (BUY SETUP)
• Target Upside: +6.2% (T1) to +10.5% (T2)
• Max Downside Stop: -4.5% Hard Floor (2.3 : 1 R/R)
Big-bank infrastructure lender breaking out with a -4.5% stop floor. Enter your email below for the entry zone and target.
Horizon: 5–12 Trading Days (Relative-Strength Financials Breakout)
⚡ See Setups #2 & #3 Right Now + Tomorrow's 3 Setups at 8:00 AM ET
Free impersonal market research. Educational levels only — past setups include losing stops and carry real risk of loss.
2. Guru Strategy Screeners, Formula Hub & Head-to-Head Battles
LIVE TAPE